7BB-10511-33004
3 vaccinations
2 coded responses
14 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 936 / CA
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-25
Dose 1 — Pfizer-BioNTech
-
2021-01-27
Registered in v-safe
-
2021-01-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-28
- 2021-01-29
-
2021-02-03
Health check-in — day 7, dose 1Feeling: Good · Fatigue or tiredness, Diarrhea, Abdominal painAdult check-in
- 2021-02-10
-
2021-02-22
Dose 2 — Pfizer-BioNTech
- 2021-02-22
-
2021-02-23
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-25
- 2021-02-28
-
2021-05-24
Survey response — 3 months, dose 2MedDRA: Delivery, Postpartum haemorrhage, Premature separation of placenta — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Symptoms: This is late reporting, but on 3/6/21 I had a placental abruption. Then I had recurrent bleeding until 8 weeks postpartum. May be unrelated, but better to report in case theres a trend. · Healthcare visit (other): This was for childbirth after the placental abruption.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-24
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-03
- 2021-08-23
-
2021-11-05
Dose 3 — Pfizer-BioNTech
-
2021-11-07
Survey response — days 1–6 daily, dose 3MedDRA: Vaginal haemorrhage — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Unexpected vaginal bleedingMedDRA releases: 2024-11 · check-in free text available
- 2021-11-09
- 2021-12-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Pfizer-BioNTech | |
| 2 | 2021-02-22 | Pfizer-BioNTech | |
| 3 | 2021-11-05 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-24 | Unsuccessful |
Free text
Release 8 — 3 months, dose 2
Symptoms: This is late reporting, but on 3/6/21 I had a placental abruption. Then I had recurrent bleeding until 8 weeks postpartum. May be unrelated, but better to report in case theres a trend.
Healthcare visit (other): This was for childbirth after the placental abruption.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Unexpected vaginal bleeding
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Delivery | ✓ | ✓ | ✓ |
| HCVO | Premature separation of placenta | ✓ | ✓ | ✓ |
| SD | Postpartum haemorrhage | ✓ | ✓ | ✓ |
| SD | Premature separation of placenta | ✓ | ✓ | ✓ |
| SRO | Vaginal haemorrhage | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release